Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing

Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing

miR-26b has been implicated in a wide range of human diseases, including cancer, diabetes, heart disease, Alzheimer’s disease and osteoarthritis. To provide a tool to explore the importance of miR-26b in this broad context, we have generated and characterized a homozygous miR-26b stem-loop knockout...

Full description

Bibliographic Details
Main Authors:	Louise H.W. Kung, Lisa Sampurno, Christopher B. Little, Shireen R. Lamandé, John F. Bateman
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506120304190

Similar Items

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Kung, Louise HW, et al.
Published: (2022)

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Louise H.W. Kung, et al.
Published: (2020-10-01)

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Kung, Louise H.W, et al.
Published: (2022)

Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing
by: Jinia Lilianty, et al.
Published: (2021-10-01)

Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing
by: Yudha Nur Patria, et al.
Published: (2020-01-01)

CRISPR/Cas9 gene editing of a SOX9 reporter human iPSC line to produce two TRPV4 patient heterozygous missense mutant iPSC lines, MCRIi001-A-3 (TRPV4 p.F273L) and MCRIi001-A-4 (TRPV4 p.P799L)
by: Yudha Nur Patria, et al.
Published: (2020-10-01)

Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing
by: Jinia Lilianty, et al.
Published: (2020-05-01)

Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing
by: Hani Hosseini Far, et al.
Published: (2019-05-01)

Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing
by: S. Merkert, et al.
Published: (2021-01-01)

The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line
by: Sara Howden, et al.
Published: (2019-07-01)

Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
by: Elena Navarro-Guerrero, et al.
Published: (2021-02-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene
by: Bailing Zu, et al.
Published: (2021-10-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus
by: Stefanie Schuster, et al.
Published: (2019-01-01)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
by: Melissa Conti Mazza, et al.
Published: (2021-08-01)

Generation and validation of APOE knockout human iPSC-derived cerebral organoids
by: Yuka A. Martens, et al.
Published: (2021-06-01)

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology
by: Ji-Zhen Lu, et al.
Published: (2021-10-01)

Generation of hemophilia B model hepatocyte derived from human iPSC via CRISPR/Cas9 mediated genome editing
by: Kwak, Peter
Published: (2018)

CRISPR/Cas9 mediated generation of a iPSC line EHTJUi005-A-1 with homozygous knockout of the SUV39H1 gene
by: Zhi-Bin Qiao, et al.
Published: (2021-10-01)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

iPSC for modeling neurodegenerative disorders
by: Valeria Valadez-Barba, et al.
Published: (2020-12-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

iPSC Bioprinting: Where are We at?
by: Sara Romanazzo, et al.
Published: (2019-08-01)

The use of the CRISPR-Cas9 system and iPSC-derived neurons with a SNCA mutation to model neurodegeneration
by: Mosaku, Olukunbi Eniola
Published: (2018)

Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7
by: E.V. Dementyeva, et al.
Published: (2020-07-01)

Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts
by: María Questa, et al.
Published: (2016-03-01)

Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency
by: Julio Castaño, et al.
Published: (2021-08-01)

Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in
by: Laura Krumm, et al.
Published: (2021-10-01)

Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
by: Andrew M. Tidball, et al.
Published: (2017-09-01)

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
by: Amy McTague, et al.
Published: (2021-03-01)

Generation of IDUA knockout cell lines by CRISPR/Cas mediated genome editing
by: Ali Hatami bardar, et al.
Published: (2021-01-01)

The Global Alliance for iPSC Therapies (GAiT)
by: Stephen Sullivan, et al.
Published: (2020-12-01)

Human iPSC banking: barriers and opportunities
by: Ching-Ying Huang, et al.
Published: (2019-10-01)

The ROSA26-iPSC Mouse: A Conditional, Inducible, and Exchangeable Resource for Studying Cellular (De)Differentiation
by: Lieven Haenebalcke, et al.
Published: (2013-02-01)

Establishment of a GFP::LMNB1 knockin cell line (CSUi002-A-1) from a dystonia patient-specific iPSC by CRISPR/Cas9 editing
by: Yu Tang, et al.
Published: (2021-08-01)

Reversal of the Inflammatory Responses in Fabry Patient iPSC-Derived Cardiovascular Endothelial Cells by CRISPR/Cas9-Corrected Mutation
by: Hui-Yung Song, et al.
Published: (2021-02-01)

Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9
by: Ambrin Fatima, et al.
Published: (2020-04-01)

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
by: Atossa Shaltouki, et al.
Published: (2015-05-01)

A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation
by: Ignacio Rodriguez-Polo, et al.
Published: (2021-07-01)

Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
by: Chul-Yong Park, et al.
Published: (2015-10-01)

Cannot write session to /tmp/vufind_sessions/sess_7fbuj279k8j4mmk1i4di943c5h